Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Spero Therapeutics Appoints Debra Jeske Zack As Chief Medical Officer

PUBLIC · SPROJul 27, 2026•13 days ago

Position

Chief Medical Officer

Company

Spero Therapeutics

Debra Jeske Zack
CambridgeBiotechnology

Description

Spero Therapeutics has appointed Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer. She brings significant experience in immunology and rheumatology at a critical time when the company is advancing its SP001 antibody program into clinical development.

Company Information

Company

Spero Therapeutics

Location

675 MASSACHUSETTS AVENUE

Cambridge, Maryland, United States

About

Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and MDR bacterial infections with high unmet need.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Spero Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.